MedPath

effect of doxycycline on asthma_like infectio

Phase 2
Conditions
Asthma.
Asthma
Registration Number
IRCT20220412054507N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patient older than 18 years with new infection with asthma-like symptoms and signs for more than 6 weeks like cough,dyspnea,stimulation with environmental factors and obstructive spirometry with reversibility of more than 12% with short-acting beta-agonist

Exclusion Criteria

Pregnancy/GERD/Sensivity to Doxycycline/ Liver diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Asthma treatment. Timepoint: In the beginning of the study, one and two months after taking the drugs. Method of measurement: ACT Questionnaire, Spirometry and Clinical sings and symptoms.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath